5187 - Cancer: Drugs (Answered)

Mr Jamie Reed
To ask the Secretary of State for Health, when the next prioritisation process for treatments currently on the National Cancer Drugs Fund list will take place.

George Freeman

I refer the hon. Member to the answer I gave on 30 June 2015 to Question 3814.

4945 - Drugs: Finance (Answered)

Mrs Cheryl Gillan
To ask the Secretary of State for Health, if he will take steps to establish a ring-fenced fund for (a) the provision of and (b) research into drugs for rare diseases.

George Freeman

Rare disease drugs are handled through the NHS England specialised commissioning budget. National Health Service commissioners are responsible for making funding decisions on drugs for rare diseases, taking into account guidance from the National Institute for Health and Care Excellence.

5756 - Clinical Trials (Answered)

Stephen McPartland
To ask the Secretary of State for Health, with reference to the announcement by the Prime Minister at the G7 Summit that all UK-funded clinical trials will be made openly available, what steps he is taking to require companies to publish such trials; and which diseases will be covered.

George Freeman

4141 - Hepatitis: Drugs (Answered)

Grahame Morris
To ask the Secretary of State for Health, what representations he has received from NICE on the timely implementation of its recommendations on the availability of new drugs for the treatment of Hepatitis C.

George Freeman

4139 - Drugs (Answered)

Grahame Morris
To ask the Secretary of State for Health, what steps he is taking to ensure that recommendations by NICE on the availability of new drug treatments are fully implemented by NHS England.

George Freeman

National Health Service commissioners, including NHS England for its directly commissioned services, are legally required to fund drugs and treatments recommended in National Institute for Health and Care Excellence (NICE) technology appraisal guidance, normally within three months of the publication of NICE’s guidance.

4128 - Prescription Drugs: Waste Disposal (Answered)

Mrs Madeleine Moon
To ask the Secretary of State for Health, what estimate he has made of the annual cost of destroyed unused prescribed medication; and if he will make a statement.

George Freeman

Information is not held centrally on the annual cost or amount of unused or unnecessary medicines in the National Health Service.

3998 - Heart Diseases (Answered)

Richard Benyon
To ask the Secretary of State for Health, what plans his Department has to task NICE with publication of guidelines for heart valve disease.

George Freeman

From April 2013, NHS England is the lead commissioner for clinical guidelines for topics which have a principal focus on healthcare.

4327 - Statins (Answered)

David Simpson
To ask the Secretary of State for Health, how his Department evaluates the effectiveness of statins used in the NHS.

George Freeman

4140 - Drugs (Answered)

Grahame Morris
To ask the Secretary of State for Health, what role is played by NHS England in deciding on the cost-effectiveness of new drug treatments.

George Freeman

The National Institute for Health and Care Excellence (NICE) is the independent body that advises the National Health Service on the clinical and cost effectiveness of selected new drugs and treatments.

4399 - Health Services (Answered)

Mr Virendra Sharma
To ask the Secretary of State for Health, on what date NHS England plans to publish decisions made by its Specialised Commissioning Committee on the draft clinical commissioning policies for (a) Duodopa for advanced Parkinson's disease and (b) other specialised services that are currently under consideration.

George Freeman

Funding decisions on new treatments for rare diseases will be made at NHS England's Specialised Commissioning Committee which is taking place on 30 June.

Pages